A third-generation herpesvirus is effective against gastroesophageal cancer

Joyce Wong1, Kaitlyn Kelly, Arjun Mittra

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

Abstract

Insights

A novel oncolytic herpesvirus effectively infected and killed gastroesophageal cancer cells in vitro. This replication-competent virus shows promise as a new therapeutic strategy for this deadly cancer.

Area of Science:

  • Oncolytic virotherapy
  • Cancer biology
  • Virology

Background:

  • Gastroesophageal cancer is a leading cause of cancer mortality, often fatal with metastasis or recurrence.
  • Current treatment options for advanced gastroesophageal cancer are limited.
  • Novel therapeutic strategies are urgently needed.

Purpose of the Study:

  • To evaluate the efficacy of a third-generation, replication-competent oncolytic herpes simplex type 1 virus against gastroesophageal cancer.
  • To assess the virus's cytotoxic effects and replication capabilities in human gastroesophageal cancer cell lines.

Main Methods:

  • Tested the cytotoxic effect of the oncolytic virus on six human gastroesophageal cancer cell lines at various multiplicities of infection (MOI).
  • Measured cytotoxicity using a lactate dehydrogenase assay.
  • Assessed viral replication through plaque assays and correlated cytotoxicity with viral replication.

Main Results:

  • All tested gastroesophageal cancer cell lines were susceptible to viral infection, showing dose-dependent cytotoxicity.
  • Higher MOIs resulted in faster and greater cancer cell death.
  • The virus replicated effectively in the cell lines, with some supporting over 40,000x amplification.
  • Cell lines with shorter doubling times exhibited faster cell kill (average 2.3 days) compared to those with longer doubling times (average 4.4 days).

Conclusions:

  • The third-generation oncolytic herpesvirus demonstrates significant potential for treating gastroesophageal cancer.
  • The virus effectively infects and lyses gastroesophageal cancer cells.
  • This oncolytic herpesvirus may represent a novel therapeutic approach for gastroesophageal cancer.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...